The Oncology Institute to Participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference CERRITOS, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the Noble Capital Markets Emerging Growth Virtual Equity Conference, on October 8, 2025, including a presentation at 11:00am ET. Interested parties can access a webcast of the presentation by registering at the link l...
The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care CERRITOS, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute (NASDAQ: TOI), a pioneer in value-based community oncology care, is pleased to announce a new partnership with Protocol Behavioral Health, a leading provider of evidence-based mental health care for cancer patients. This collaboration underscores TOI’s commitment to delivering whole-person care by integrating behavioral health services directly into the cancer care journey. Research shows that appr...
SAIC Announces Pricing of $500.0 Million in Senior Notes RESTON, Va., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: ) (“SAIC”), a premier Fortune 500 technology integrator driving our nation's digital transformation across the defense, space, civilian, and intelligence markets, announced today that it has priced an offering of $500.0 million aggregate principal amount of 5.875% senior notes due 2033 (the “Notes”). The Notes were priced at 100% of their principal amount and will be senior unsecured obligations of SAIC. The offering is expected to clos...
Moody's Ratings (Moody's) affirmed the ratings of Science Applications International Corporation (SAIC), including the Ba2 corporate family rating (CFR), the Ba2-PD probability of default rating and the Ba1 rating on the company's existing senior secured bank credit facilities. Concurrently, we assi...
SAIC Announces Second Quarter of Fiscal Year 2026 Results Revenues of $1.77 billion; approximately (3)% revenue contraction Net bookings of $2.6 billion; book-to-bill ratio of 1.5, trailing twelve months book-to-bill ratio of 1.0Year-to-date net bookings of $5.0 billion; year-to-date book-to-bill ratio of 1.4Net income of $127 million; Adjusted EBITDA(1) of $185 million or 10.5% of revenuesDiluted earnings per share of $2.71; Adjusted diluted earnings per share(1) of $3.63Cash flows provided by operating activities of $122 million; Free cash flow(1) of $150 millionManagement lowers revenue...
The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos CERRITOS, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a leading value-based oncology practice, today announced the launch of its Lung Cancer Center of Excellence in Fort Lauderdale, Florida. The new center will be led by world-renowned thoracic oncologist Dr. Edgardo S. Santos Castillero, whose career has been defined by groundbreaking research, clinical excellence, and a deep commitment to patient c...
SAIC Board of Directors Declares Cash Dividend RESTON, Va., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: ) announced today that the company’s board of directors declared a cash dividend of $0.37 per share of the company’s common stock payable on October 24, 2025 to stockholders of record on October 10, 2025. SAIC intends to continue paying dividends on a quarterly basis, although the declaration of any future dividends will be determined by the board of directors each quarter and will depend on earnings, financial condition, capital requirements and...
Victoria’s Secret & Co. to Present at the Goldman Sachs 32nd Annual Global Retailing Conference REYNOLDSBURG, Ohio, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) announced today that Hillary Super, Chief Executive Officer, and Scott Sekella, Chief Financial and Operating Officer, will participate in a fireside chat at the Goldman Sachs 32nd Annual Global Retailing conference on Thursday, September 4, 2025, at 1:10 p.m. ET. A live audio webcast will be available at the time of the event and may be accessed through the Investors section o...
Victoria’s Secret & Co. Reports Second Quarter 2025 Results Second quarter sales, operating income and EPS exceed expectations Second quarter comparable sales up 4% Company raises full year 2025 sales guidance REYNOLDSBURG, Ohio, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Victoria’s Secret & Co. (“VS&Co” or the “Company”) (NYSE: VSCO) today reported financial results for the second quarter ended August 2, 2025. “I am excited to share that our momentum continued building in the second quarter, once again delivering results that beat our sales and operating income guidance. We delivered comparab...
SAIC Schedules Second Quarter Fiscal Year 2026 Earnings Conference Call for September 4 at 10 A.M. ET RESTON, Va., Aug. 21, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: ) is scheduled to issue its second quarter fiscal year 2026 results before market open on Thursday, September 4, 2025. SAIC executive management will discuss operational and financial results in a conference call beginning at 10:00 a.m. Eastern time, following the issuance of the company’s earnings press release. The conference call will be webcast simultaneously to the public through a lin...
The Oncology Institute and Doctors Healthcare Plans Partner to Elevate Oncology Care Management in South Florida CERRITOS, Calif., Aug. 18, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ: TOI), a national leader in value-based oncology care, is pleased to announce a strategic partnership with Doctors HealthCare Plans, a Medicare Advantage plan serving members across South Florida. The Oncology Institute will provide delegated utilization management services and clinical advisory support, helping Doctors HealthCare Plans ensure high-quality, cost-effective c...
The Oncology Institute Reports Second Quarter 2025 Financial Results and Reaffirms Full Year 2025 Guidance CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended June 30, 2025. Daniel Virnich, CEO of TOI, commented, "We delivered another strong quarter with over 20% year-over-year revenue growth. This was driven by exceptional performance in our pharmacy business, which grew over 40% ...
The Oncology Institute Announces Changes to Board of Directors Richard Barasch to Retire; Anne McGeorge Brings Extensive Financial Experience to Role as New Chairman CERRITOS, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Richard Barasch will retire from his role as Chairman of the Board, effective August 12, 2025. Anne McGeorge, who currently serves as a Board Member and Chair of the Audit Committee, will succeed Barasch in the role. “We are thrille...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.